Endocrinology, Diabetes & Metabolism Doctors in Gulfport, MS Accepting Medicare

3 Endocrinology, Diabetes & Metabolism doctors found. Showing 1 - 3

Dr. Mark D Borchelt, MD, FACE Internal Medicine - Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 4540 W Railroad St, Gulfport, MS 39501 Phone: 228-867-6062    Fax: 228-867-2598

Ellen Dauterive Caswell, MD Internal Medicine - Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 8950 Lorraine Rd Ste B, Gulfport, MS 39503 Phone: 228-822-6770    Fax: 228-896-5374

Dr. Beverly Lansden, M.D. Internal Medicine - Endocrinology, Diabetes & Metabolism Medicare: Not Enrolled in Medicare Practice Location: 4540 W Railroad St, Gulfport, MS 39501 Phone: 228-867-6062    Fax: 228-867-2598

News Archive

Next-generation sequencing provides important clues to traceback foodborne illness outbreak

FDA scientists successfully used a new genome sequencing test to retrospectively examine a 2009-10 foodborne illness outbreak to help trace the source of the infection.

Sequester scare touches issues related to Medicare, Medicaid spending

The $85 billion in scheduled spending cuts to defense and discretionary accounts are scheduled to kick in Friday, and movement toward a last-ditch strategy has not been evident.

AbSorber receives patent protection for its XM-ONE in the European countries

AbSorber has received patent protection for its transplantation cross match-test XM-ONE® in the European countries. The patent was previously approved in New Zealand which was the first country to approve a patent for AbSorbers product.

Westone to launch TRU hearing protection earpieces at 2014 NAMM Show

Westone, the leader in high performance audio and in-ear monitoring technology, will launch their TRU™ Custom and Universal hearing protection earpieces at the 2014 NAMM Show.

VeriChip to commence Phase II development of an in vivo glucose-sensing RFID microchip

VeriChip Corporation and its development partner RECEPTORS LLC, a technology company whose AFFINITY by DESIGN chemistry platform can be applied to the development of selective binding products, announced today that VeriChip plans to fund its existing development partnership with RECEPTORS to launch Phase II development of an in vivo glucose-sensing RFID microchip.

Read more Medical News

› Verified 2 days ago